• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺乳头状癌滤泡亚型:6例临床病理研究

Follicular variant of thyroid papillary carcinoma: a clinicopathologic study of six cases.

作者信息

Chem K T, Rosai J

出版信息

Am J Surg Pathol. 1977 Jun;1(2):123-30. doi: 10.1097/00000478-197706000-00003.

DOI:10.1097/00000478-197706000-00003
PMID:602974
Abstract

The clinicopathologic features of six cases of a peculiar variant of differentiated carcinoma of the thyroid composed of follicles with or without solid areas and having a characteristics ground-glass appearance of the nuclei were studied and compared with those of conventional papillary and follicular carcinomas. This variant resembled papillary carcinoma in its biologic behavior and all morphologic features with the exception that papillae were not present. The term "papillary carcinoma, follicular variant" is proposed for this tumor type in order to emphasize its close biologic relationship with the conventional papillary carcinoma.

摘要

对6例甲状腺分化癌特殊变异型的临床病理特征进行了研究,该变异型由有或无实性区域的滤泡组成,细胞核具有特征性的磨砂玻璃样外观,并与传统乳头状癌和滤泡状癌的特征进行了比较。除了没有乳头外,该变异型在生物学行为和所有形态学特征上类似于乳头状癌。为了强调这种肿瘤类型与传统乳头状癌密切的生物学关系,建议将其命名为“滤泡变异型乳头状癌”。

相似文献

1
Follicular variant of thyroid papillary carcinoma: a clinicopathologic study of six cases.甲状腺乳头状癌滤泡亚型:6例临床病理研究
Am J Surg Pathol. 1977 Jun;1(2):123-30. doi: 10.1097/00000478-197706000-00003.
2
New subgrouping of small thyroid carcinomas.甲状腺微小癌的新亚组分类。
Cancer. 1987 Oct 15;60(8):1767-70. doi: 10.1002/1097-0142(19871015)60:8<1767::aid-cncr2820600816>3.0.co;2-p.
3
Papillary carcinoma of the thyroid. A discussion of its several morphologic expressions, with particular emphasis on the follicular variant.
Am J Surg Pathol. 1983 Dec;7(8):809-17.
4
Clinicopathological studies of minimal thyroid and ordinary thyroid cancers.
Jpn J Surg. 1984 Mar;14(2):110-7. doi: 10.1007/BF02469800.
5
Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.甲状腺乳头状癌滤泡状变体的临床表现及手术治疗结果
Jpn J Clin Oncol. 2006 Nov;36(11):688-93. doi: 10.1093/jjco/hyl093. Epub 2006 Sep 25.
6
Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.致命性非间变性滤泡细胞源性甲状腺癌的临床病理特征
Thyroid. 2016 Nov;26(11):1588-1597. doi: 10.1089/thy.2016.0247. Epub 2016 Sep 7.
7
[Multicentric papillary and follicular carcinomas of the thyroid].[甲状腺多中心乳头状癌和滤泡状癌]
Gan No Rinsho. 1988 Aug;34(9):1147-51.
8
[Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis--a meta-analysis].[分化型甲状腺癌和C细胞癌淋巴结转移对预后的意义——一项荟萃分析]
Zentralbl Chir. 1997;122(4):259-65.
9
Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.具有小梁状、岛状和实性结构的甲状腺低分化癌:183例患者的临床病理研究
Cancer. 2004 Mar 1;100(5):950-7. doi: 10.1002/cncr.20087.
10
Factors predictive of lymph node metastasis in the follicular variant of papillary thyroid carcinoma.预测甲状腺滤泡型乳头状癌淋巴结转移的相关因素。
Br J Surg. 2013 Sep;100(10):1312-7. doi: 10.1002/bjs.9210.

引用本文的文献

1
Revisionist history uncovers a simplified molecular-based classification of differentiated thyroid cancer.修正主义历史揭示了一种基于分子的分化型甲状腺癌简化分类。
J Pathol. 2025 Oct;267(2):130-141. doi: 10.1002/path.6456. Epub 2025 Aug 5.
2
Non-Invasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features (NIFTPs).具有乳头样核特征的非侵袭性滤泡性甲状腺肿瘤(NIFTPs)
Kaohsiung J Med Sci. 2025 Jun;41(6):e70051. doi: 10.1002/kjm2.70051. Epub 2025 May 31.
3
Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): what do we need to know?
具有乳头状核特征的非侵袭性滤泡性甲状腺肿瘤(NIFTP):我们需要了解什么?
Virchows Arch. 2024 Dec;485(6):977-987. doi: 10.1007/s00428-024-03953-y. Epub 2024 Oct 23.
4
Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features: What a Surgeon Should Know.具有乳头状核特征的非侵袭性滤泡性甲状腺肿瘤:外科医生应了解的内容。
Cureus. 2023 Jan 11;15(1):e33649. doi: 10.7759/cureus.33649. eCollection 2023 Jan.
5
Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): Tumour Entity with a Short History. A Review on Challenges in Our Microscopes, Molecular and Ultrasonographic Profile.具有乳头状核特征的非侵袭性滤泡性甲状腺肿瘤(NIFTP):一种新发现的肿瘤实体。关于显微镜、分子及超声特征方面挑战的综述
Diagnostics (Basel). 2022 Jan 20;12(2):250. doi: 10.3390/diagnostics12020250.
6
The contribution of molecular pathology to the classification of thyroid tumors.分子病理学在甲状腺肿瘤分类中的贡献。
Diagn Histopathol (Oxf). 2018 Mar;24(3):87-94. doi: 10.1016/j.mpdhp.2018.02.001.
7
HBME1 and CK19 expression in non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) vs other follicular patterned thyroid lesions.具有乳头状核特征的非侵袭性滤泡性甲状腺肿瘤(NIFTP)与其他滤泡型甲状腺病变中HBME1和CK19的表达情况
World J Surg Oncol. 2021 May 8;19(1):143. doi: 10.1186/s12957-021-02258-7.
8
Sonographic features of follicular variant of papillary thyroid carcinoma (FV-PTC) and diagnostic performance of the 2017 ACR TI-RADS in FV-PTC.甲状腺乳头状癌滤泡亚型(FV-PTC)的超声特征及2017版美国放射学会(ACR)甲状腺影像报告和数据系统(TI-RADS)对FV-PTC的诊断效能
Endocrine. 2020 Feb;67(2):379-386. doi: 10.1007/s12020-019-02184-5. Epub 2020 Jan 9.
9
A 15 year institutional experience of well-differentiated follicular cell-derived thyroid carcinomas; impact of the new 2017 TNM and WHO Classifications of Tumors of Endocrine Organs on the epidemiological trends and pathological characteristics.15年高分化滤泡细胞源性甲状腺癌的机构经验;2017年新版内分泌器官肿瘤TNM和世界卫生组织分类对流行病学趋势及病理特征的影响
Endocrine. 2020 Mar;67(3):630-642. doi: 10.1007/s12020-019-02158-7. Epub 2019 Dec 14.
10
[Morphologic diagnostic criteria of noninvasive follicular neoplasia with papillary-like nuclear features (NIFTP) : A diagnostic challenge for the patient's benefit].[具有乳头样核特征的非侵袭性滤泡性肿瘤(NIFTP)的形态学诊断标准:为患者利益面临的诊断挑战]
Pathologe. 2019 May;40(3):220-226. doi: 10.1007/s00292-019-0597-0.